2025-03-26 |
2025-03-25 |
VP
Vente planifiée
|
Sullivan Mark
Chief Legal Officer
Dirigeant
|
6 576
-2.0%
6,74
44 322 USD
|
6 576
-2.0%
|
6,74
|
44 322 USD
|
|
2025-03-26 |
2025-03-25 |
VP
Vente planifiée
|
Liao Carrie
Chief Accounting Officer
Dirigeant
|
2 347
-1.6%
6,74
15 819 USD
|
2 347
-1.6%
|
6,74
|
15 819 USD
|
|
2025-03-26 |
2025-03-25 |
VP
Vente planifiée
|
Karlin Daniel
Chief Medical Officer
Dirigeant
|
6 836
-1.5%
6,74
46 075 USD
|
6 836
-1.5%
|
6,74
|
46 075 USD
|
|
2025-03-26 |
2025-03-25 |
VP
Vente planifiée
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
21 208
-2.4%
6,74
142 942 USD
|
21 208
-2.4%
|
6,74
|
142 942 USD
|
|
2024-12-27 |
2024-12-26 |
VP
Vente planifiée
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
6 643
-1.9%
7,43
49 357 USD
|
6 643
-1.9%
|
7,43
|
49 357 USD
|
|
2024-12-27 |
2024-12-26 |
VP
Vente planifiée
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
19 106
-3.5%
7,43
141 958 USD
|
19 106
-3.5%
|
7,43
|
141 958 USD
|
|
2024-12-27 |
2024-12-26 |
VP
Vente planifiée
|
Sullivan Mark
Chief Legal Officer
Dirigeant
|
4 519
-2.5%
7,43
33 576 USD
|
4 519
-2.5%
|
7,43
|
33 576 USD
|
|
2024-12-27 |
2024-12-26 |
VP
Vente planifiée
|
Liao Carrie
Chief Accounting Officer
Dirigeant
|
2 273
-2.3%
7,43
16 888 USD
|
2 273
-2.3%
|
7,43
|
16 888 USD
|
|
2024-12-05 |
2024-12-05 |
A
Achat
|
GRYSKA DAVID W
Administrateur non-exécutif
|
2 500
+14.4%
7,17
17 925 USD
|
2 500
+14.4%
|
7,17
|
17 925 USD
|
|
2024-09-25 |
2024-09-25 |
VP
Vente planifiée
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
19 771
-3.5%
5,98
118 231 USD
|
19 771
-3.5%
|
5,98
|
118 231 USD
|
|
2024-09-25 |
2024-09-25 |
VP
Vente planifiée
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
6 871
-2.0%
5,98
41 089 USD
|
6 871
-2.0%
|
5,98
|
41 089 USD
|
|
2024-09-25 |
2024-09-25 |
VP
Vente planifiée
|
Sullivan Mark
Chief Legal Officer
Dirigeant
|
4 430
-2.4%
5,98
26 491 USD
|
4 430
-2.4%
|
5,98
|
26 491 USD
|
|
2024-09-25 |
2024-09-25 |
VP
Vente planifiée
|
Liao Carrie
Chief Accounting Officer
Dirigeant
|
2 352
-2.3%
5,98
14 065 USD
|
2 352
-2.3%
|
5,98
|
14 065 USD
|
|
2024-08-26 |
2024-08-23 |
A
Achat
|
GRYSKA DAVID W
Administrateur non-exécutif
|
3 500
+25.3%
5,98
20 930 USD
|
3 500
+25.3%
|
5,98
|
20 930 USD
|
|
2024-08-20 |
2024-08-20 |
A
Achat
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
500
+0.1%
6,12
3 060 USD
|
500
+0.1%
|
6,12
|
3 060 USD
|
|
2024-08-20 |
2024-08-19 |
A
Achat
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
500
+0.1%
6,31
3 155 USD
|
500
+0.1%
|
6,31
|
3 155 USD
|
|
2024-06-25 |
2024-06-25 |
VP
Vente planifiée
|
Sullivan Mark
Chief Legal Officer
Dirigeant
|
17 854
-8.9%
7,22
128 906 USD
|
17 854
-8.9%
|
7,22
|
128 906 USD
|
|
2024-06-25 |
2024-06-25 |
VP
Vente planifiée
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
6 925
-1.9%
7,22
49 999 USD
|
6 925
-1.9%
|
7,22
|
49 999 USD
|
|
2024-06-25 |
2024-06-25 |
VP
Vente planifiée
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
15 659
-2.7%
7,22
113 058 USD
|
15 659
-2.7%
|
7,22
|
113 058 USD
|
|
2024-03-26 |
2024-03-25 |
VP
Vente planifiée
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
16 519
-2.8%
9,50
156 931 USD
|
16 519
-2.8%
|
9,50
|
156 931 USD
|
|
2024-03-26 |
2024-03-25 |
VP
Vente planifiée
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
6 578
-1.8%
9,50
62 491 USD
|
6 578
-1.8%
|
9,50
|
62 491 USD
|
|
2023-12-26 |
2023-12-26 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
6 774
-1.8%
3,63
24 590 USD
|
6 774
-1.8%
|
3,63
|
24 590 USD
|
|
2023-12-26 |
2023-12-26 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
13 237
-2.2%
3,63
48 050 USD
|
13 237
-2.2%
|
3,63
|
48 050 USD
|
|
2023-12-26 |
2023-12-26 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
5 652
-2.5%
3,63
20 517 USD
|
5 652
-2.5%
|
3,63
|
20 517 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
3 854
-1.7%
3,58
13 797 USD
|
3 854
-1.7%
|
3,58
|
13 797 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
1 908
-0.8%
3,57
6 812 USD
|
1 908
-0.8%
|
3,57
|
6 812 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
3 240
-0.9%
3,58
11 599 USD
|
3 240
-0.9%
|
3,58
|
11 599 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
3 678
-1.0%
3,57
13 130 USD
|
3 678
-1.0%
|
3,57
|
13 130 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
8 231
-1.3%
3,58
29 467 USD
|
8 231
-1.3%
|
3,58
|
29 467 USD
|
|
2023-09-25 |
2023-09-25 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
5 268
-0.8%
3,57
18 807 USD
|
5 268
-0.8%
|
3,57
|
18 807 USD
|
|
2023-08-28 |
2023-08-25 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
20 000
-8.1%
3,80
76 000 USD
|
20 000
-8.1%
|
3,80
|
76 000 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
3 941
-1.6%
3,21
12 651 USD
|
3 941
-1.6%
|
3,21
|
12 651 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Greenway Schond L.
Chief Financial Officer
Dirigeant
|
7 694
-3.0%
3,19
24 544 USD
|
7 694
-3.0%
|
3,19
|
24 544 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
2 963
-0.8%
3,21
9 511 USD
|
2 963
-0.8%
|
3,21
|
9 511 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
3 820
-1.0%
3,19
12 186 USD
|
3 820
-1.0%
|
3,19
|
12 186 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
8 416
-1.3%
3,21
27 015 USD
|
8 416
-1.3%
|
3,21
|
27 015 USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
7 086
-1.1%
3,19
22 604 USD
|
7 086
-1.1%
|
3,19
|
22 604 USD
|
|
2023-03-02 |
2023-03-01 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
3 577
-1.4%
3,51
12 555 USD
|
3 577
-1.4%
|
3,51
|
12 555 USD
|
|
2023-03-02 |
2023-03-01 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
8 273
-3.3%
3,51
29 038 USD
|
8 273
-3.3%
|
3,51
|
29 038 USD
|
|
2022-12-22 |
2022-12-21 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
1 211
-0.5%
2,69
3 258 USD
|
1 211
-0.5%
|
2,69
|
3 258 USD
|
|
2022-12-22 |
2022-12-21 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
3 861
-1.5%
2,69
10 386 USD
|
3 861
-1.5%
|
2,69
|
10 386 USD
|
|
2022-10-27 |
2022-10-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
644
-0.2%
3,00
1 932 USD
|
644
-0.2%
|
3,00
|
1 932 USD
|
|
2022-10-27 |
2022-10-25 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
541
-0.2%
2,81
1 520 USD
|
541
-0.2%
|
2,81
|
1 520 USD
|
|
2022-10-25 |
2022-10-25 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
1 207
-0.5%
2,81
3 392 USD
|
1 207
-0.5%
|
2,81
|
3 392 USD
|
|
2022-10-18 |
2022-10-18 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
1 220
-0.5%
3,11
3 794 USD
|
1 220
-0.5%
|
3,11
|
3 794 USD
|
|
2022-09-27 |
2022-09-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
640
-0.2%
5,87
3 757 USD
|
640
-0.2%
|
5,87
|
3 757 USD
|
|
2022-09-27 |
2022-09-26 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
565
-0.2%
5,51
3 113 USD
|
565
-0.2%
|
5,51
|
3 113 USD
|
|
2022-09-27 |
2022-09-26 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
1 264
-0.5%
5,51
6 965 USD
|
1 264
-0.5%
|
5,51
|
6 965 USD
|
|
2022-09-19 |
2022-09-16 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
1 350
-0.5%
7,26
9 801 USD
|
1 350
-0.5%
|
7,26
|
9 801 USD
|
|
2022-09-01 |
2022-08-31 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
1 228
-0.5%
11,67
14 331 USD
|
1 228
-0.5%
|
11,67
|
14 331 USD
|
|
2022-09-01 |
2022-08-31 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
1 204
-0.4%
11,67
14 051 USD
|
1 204
-0.4%
|
11,67
|
14 051 USD
|
|
2022-08-17 |
2022-08-16 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
20 350
-0.5%
0,68
13 838 USD
|
20 350
-0.5%
|
0,68
|
13 838 USD
|
|
2022-07-27 |
2022-07-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
9 856
-0.2%
0,69
6 801 USD
|
9 856
-0.2%
|
0,69
|
6 801 USD
|
|
2022-07-27 |
2022-07-25 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
8 361
-0.2%
0,69
5 769 USD
|
8 361
-0.2%
|
0,69
|
5 769 USD
|
|
2022-07-26 |
2022-07-25 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
18 681
-0.5%
0,69
12 890 USD
|
18 681
-0.5%
|
0,69
|
12 890 USD
|
|
2022-07-18 |
2022-07-18 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
19 388
-0.5%
0,70
13 572 USD
|
19 388
-0.5%
|
0,70
|
13 572 USD
|
|
2022-06-28 |
2022-06-27 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
36 762
-0.9%
0,70
25 733 USD
|
36 762
-0.9%
|
0,70
|
25 733 USD
|
|
2022-06-28 |
2022-06-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
26 238
-0.6%
0,70
18 367 USD
|
26 238
-0.6%
|
0,70
|
18 367 USD
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
21 275
-0.5%
0,70
14 893 USD
|
21 275
-0.5%
|
0,70
|
14 893 USD
|
|
2022-05-31 |
2022-05-27 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
9 555
-0.2%
0,82
7 835 USD
|
9 555
-0.2%
|
0,82
|
7 835 USD
|
|
2022-05-26 |
2022-05-25 |
V
Vente
|
Barrow Robert
Chief Executive Officer
Administrateur exécutif
|
18 415
-0.5%
0,77
14 180 USD
|
18 415
-0.5%
|
0,77
|
14 180 USD
|
|
2022-05-26 |
2022-05-25 |
V
Vente
|
Karlin Dan
Chief Medical Officer
Dirigeant
|
8 242
-0.2%
0,77
6 346 USD
|
8 242
-0.2%
|
0,77
|
6 346 USD
|
|